• What are the non-negotiables for building an investable company?
• Platform vs product: does clinical proximity outweigh broad platforms?
• Building partnership models that preserve value
• Where is AI providing acceleration?
Moderator:
TIM HARRIS, Venture Partner, SV Health Investors
Panellists:
IULIAN PRUTEANU-MALINICI, Senior Director of Bioinformatics for Pioneering Medicines, Flagship Pioneering
IRENE GHOBRIAL, Professor of Medicine, Senior Vice President of Experimental Therapy, Lavine Family Chair for Preventative Cancer Therapy, Dana-Farber Cancer Institute
JEFF JUNE, Chief Executive Officer, Ischemia Care
HAGAI MARMOR-KOLLET, Investment Associate, aMoon Growth
MARIA FORERO, Senior Advisor, Accelmed
